GSK3B and Alzheimer disease: As cx-DHED treatment enhanced O-GlcNAcylation by restoring abnormal glucose metabolism, phosphorylation of GSK-3β, phosphorylated tau, and disrupted synaptic proteins were improved in AD model mice (Figure 7).